— Know what they know.
Not Investment Advice

RNXT NASDAQ

RenovoRx, Inc.
1W: -4.8% 1M: -37.3% 3M: +66.7% YTD: +89.2% 1Y: +17.9% 3Y: +21.5% 5Y: -77.5%
$1.58
+0.03 (+1.94%)
 
Weekly Expected Move ±12.0%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $71.2M mcap · 43M float · 1.41% daily turnover · Short 44% of daily vol

Balance Sheet Trends

Total Assets
$8M -0.3% ▼
5Y CAGR: +33.4%
Total Liabilities
$3M -26.6% ▼
5Y CAGR: -30.6%
Shareholders Equity
$5M +21.1% ▲
Cash & Investments
$7M -1.8% ▼
5Y CAGR: +31.4%
Total Debt
$107K -61.5% ▼
5Y CAGR: -47.9%
Net Debt
-$7M -0.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$15M$4M$1M$7M$7M
Short-Term Investments$0$2M$0$0$0
Cash & ST Investments$15M$6M$1M$7M$7M
Net Receivables$0$0$0$43K$139K
Inventory$0$0$0$0$189K
Other Current Assets$0$825K$101K$303K$541K
Total Current Assets$16M$7M$1M$8M$8M
Property, Plant & Equip.$6K$0$0$290K$202K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$6K$0$0$290K$202K
Total Assets$16M$7M$1M$8M$8M
— Liabilities —
Accounts Payable$525K$534K$561K$586K$799K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$475K$75K$817K$2M
Total Current Liabilities$938K$1M$1M$2M$2M
Long-Term Debt$0$0$0$0$107K
Other Non-Current Liab.$0$0$3M$2M$604K
Total Non-Current Liabilities$0$0$3M$2M$711K
Total Liabilities$938K$1M$4M$4M$3M
— Equity —
Common Stock$1K$1K$1K$2K$608K
Retained Earnings-$21M-$31M-$41M-$50M-$61M
Accumulated OCI-$16M$17K$0$0$0
Total Stockholders Equity$15M$6M-$3M$4M$5M
Total Liabilities & Equity$16M$7M$1M$8M$8M
— Key Metrics —
Total Debt$0$0$0$278K$107K
Net Debt-$15M-$4M-$1M-$7M-$7M
Total Investments$0$2M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms